Drug
Lipiodol
Lipiodol: highest development phase Phase 1, developed by Guerbet. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lipiodol NCT04733092 | Phase 1 | Knee Osteoarthritis |
Latest
No recent events.
Follow Lipiodol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.